Peroxisome proliferator-activated receptors for hypertension

doi:10.4330/wjc.v6.i8.744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9498)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

542

WORD

277

HTML

6170

Figures (1-4)

238

Sum=7227

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1152

Download

1119

Sum=2271

Aug 26, 2014 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (55)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Cardiol. Aug 26, 2014; 6(8): 744-754
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.744

Peroxisome proliferator-activated receptors for hypertension

Daisuke Usuda, Tsugiyasu Kanda

Daisuke Usuda, Tsugiyasu Kanda, Department of Community Medicine, Kanazawa Medical University Himi Municipal Hospital, Himi-shi 935-8531, Toyama-ken, Japan

Author contributions: Usuda D and Kanda T designed and wrote the introductory editorial for the paper.

Correspondence to: Daisuke Usuda, MD, MTM, Department of Community Medicine, Kanazawa Medical University Himi Municipal Hospital, 1130 Kurakawa, Himi-shi 935-8531, Toyama-ken, Japan. united19771108@yahoo.co.jp

Telephone: +81-766-741900 Fax: +81-766-741901

Received: December 26, 2013
Revised: June 6, 2014
Accepted: June 27, 2014
Published online: August 26, 2014

Core Tip

Core tip: Lifestyle-related diseases are major public health problem worldwide, and the prevalence of these diseases and subsequent complications has increased rapidly over the past 20 years. It has been a decade or more since the first report of the pleiotropic effects of peroxisome proliferator-activated receptors (PPARs), and numerous studies on their novel effects continue to appear every month. In addition to their effects on blood pressure, atherosclerosis, and kidney dysfunction, anti-cancer effects of PPARγ ligands have been reported recently. The effectiveness of PPAR agonists in the treatment of lifestyle-related diseases will be increasingly appreciated. This review summarizes the current literature on PPARs.